Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis by Hu Zhang, Chenlu Mu, Yu Gu, Fanyi Meng, Xiali Qin, Hailong Cao

Connect to this object online.

Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota by Yu Gu, Chen Wang, Xiali Qin, Bingqian Zhou, Xiang Liu, Tianyu Liu, Runxiang Xie, Jinghua Liu, Bangmao Wang, Hailong Cao

Connect to this object online.

A Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor by Xiali Qin, Qing Zhao, Qianjing Zhao, Lijiao Yang, Wanyu Li, Jingyi Wu, Tianyu Liu, Weilong Zhong, Kui Jiang, Wentian Liu, Bangmao Wang, Sinan Wang, Hailong Cao

Connect to this object online.